Ontology highlight
ABSTRACT:
SUBMITTER: Mayer IA
PROVIDER: S-EPMC4751984 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
Current breast cancer reports 20151010 4
Recent advances in tumor genetics and drug development have led to the generation of a wealth of anti-cancer-targeted therapies. These drugs aim at targeting a particular vulnerability in the tumor generated in most cases as a result of dependence on an oncogene and/or loss of a tumor suppressor. Genes in the phosphoinositide 3-kinase (PI3K)/AKT pathway are the most frequently altered in human cancers. Aberrant activation of the PI3K/AKT pathway has been shown to confer resistance to HER2-target ...[more]